Literature DB >> 2151332

Role of endothelin in mechanisms of local blood pressure control.

T Masaki1, M Yanagisawa, K Goto, S Kimura.   

Abstract

A potent endothelium-derived vasoconstrictive peptide, endothelin (ET), is processed from a precursor, big endothelin, by an unknown converting enzyme. It stimulates calcium channels, phospholipase C and phospholipase A2 in smooth muscle cells through activation of the receptor specific for ET. The intracellular free calcium ion concentration is increased by ET, inducing vasoconstriction. The response to ET varies according to the type of blood vessel. Mesenteric small arteries and arterioles are sensitive to ET. It is likely that various factors, including adrenaline, angiotensin II and arginine vasopressin, induce synthesis and release of ET from the endothelium. A balance among ET, endothelium-derived relaxing factor (EDRF) and atrial natriuretic peptide (ANP) may control vascular tone and regulate peripheral blood flow.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151332

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  4 in total

1.  Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus.

Authors:  E Lawrence; S D Brain
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects.

Authors:  L L Thomsen; H K Iversen; C Emmeluth; P Bie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Urinary endothelin excretion in the neonate: influence of maturity and perinatal pathology.

Authors:  E Sulyok; T Ertl; K Adamovits; S Hovanyovszky; W Rascher
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

4.  Endothelins and markers of renal damage in recently diagnosed hypertensive patients.

Authors:  Antonia Maldonado-Martín; Dolores Rueda-Illescas; Blas Gil-Extremera; Leticia Soriano-Carrascosa; Trinidad Alonso-Morales; Francisco García-Pérez; José García-Chicano; Juan de Dios Luna del Castillo
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Sep-Oct       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.